Director
UCSF
Corte Madera, CA, United States
I am the Jean S. Engleman Professor and Chief of Rheumatology, Director of the Rheumatology Clinical Research Center, clinical researcher, and practicing rheumatologist at the University of California, San Francisco. I lead an integrated clinical and research program devoted to two closely-related goals: (i) to improve our understanding of the molecular and epidemiologic basis for systemic lupus erythematosus (SLE); and (ii) to develop novel approaches for the treatment of SLE.
207: Updating the Treatment Landscape of SLE for Earlier Introduction of Biologics
Saturday, November 16, 2024
5:45 PM – 7:45 PM Eastern Time
No financial relationships with ineligible companies to disclose
Sunday, November 17, 2024
2:15 PM – 3:15 PM Eastern Time
Disclosure(s): AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing); GlaxoSmithKlein: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing)
MTP17A: Meet the Professor: Lupus Nephritis
Monday, November 18, 2024
7:30 AM – 8:30 AM Eastern Time
Disclosure(s): AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing); GlaxoSmithKlein: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing)
Applying the Updated Guidelines to Various Classes of Lupus Nephritis
Monday, November 18, 2024
10:30 AM – 10:45 AM Eastern Time
Disclosure(s): AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing); GlaxoSmithKlein: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing)
Monday, November 18, 2024
11:15 AM – 11:30 AM Eastern Time
Disclosure(s): AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing); GlaxoSmithKlein: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing)